This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. As Lonza demonstrates, sustainable practices are not just environmental imperatives but essential components of modern pharmaceuticalmanufacturing.
Blogs – A company is free to own a blog or engage a blog writer by way of sponsorship or consultancy fees. In the EU and UK, where direct-to-consumer promotion of POMs is prohibited, companies may not sponsor blogs that promote, or could reasonably be expected to promote, such products.
Insights from USP’s Medicine Supply Map demonstrate that geographic concentration of pharmaceuticalmanufacturing anywhere in the world – including within the United States – increases the risk for drug shortages. Promoting geographic diversity of the manufacturing base of U.S.
Key focus areas in sustainable manufacturing practices From drug discovery and manufacturing to packaging and patient engagement, sustainability should be embedded in every facet of pharma operations. To support MSME pharma companies in meeting these new standards, the government could implement several targeted incentives.
This R&D is not just for newer healing combinations, but also innovation across the product lifecycle (from formulation to disposal) for drugs that are less resource-intensive, increasing recyclability in packaging, and other environmental benefits like biodegradable formulations to reduce waste.
Also, the proliferation of antimicrobial resistance (AMR), where overuse of antibiotics leads to resistant bacteria, making infections harder to treat Additionally, pharmaceuticalmanufacturing consumes substantial amounts of solvents, which are typically highly toxic chemicals, as well as heavy metals.
This led to new commitments and action to expand Africa’s industrial capacity for pharmaceuticalmanufacturing. Five products, eight countries Broadly speaking, USP and RHSC seek to promote healthier markets, including through growth in regional manufacturing of health supplies in SSA.
In this article, we will discuss important aspects of equipment cleaning that are required during pharmaceuticalmanufacturing. Equipment cleaning validation protocol was not discussed intensely in this article which was covered elsewhere in this blog.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content